HDAC4 Promotes Cancer Stemness in Nonsmall Cell Lung Cancer by Upregulating SLC38A2 Expression via HIF‐1α to Enhance Glutamine Metabolism
Analytical Cellular Pathology · 2026
DOI: 10.1155/ancp/2525721 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Cellular Pathology, 2026. Verfasst von Changxian Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anorectal Diseases, The First People's Hospital of Yunnan Province, Kunming University of Science and Technology Affiliated Hospital, K…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Histone Deacetylases, Hypoxia-Inducible Factor 1, alpha Subunit, Lung Neoplasms. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Special Fund of Kunming Medical University-Key Project.
Abstract (Originalsprache)
Background and Purpose The malignant progression of nonsmall cell lung cancer (NSCLC) is closely related to cancer stemness. Histone deacetylase 4 (HDAC4) plays a regulatory role in lung cancer, but its effect on NSCLC stemness remains unclear. This study aimed to investigate the role and mechanism of HDAC4 in NSCLC stemness.
Methods
In this study, a tumor‐bearing model was established by subcutaneously injecting A549 cells into the right dorsal side of nude mice. Reverse transcription quantitative polymerase chain reaction (RT‐qPCR), Western blotting, and immunohistochemistry were used to measure gene and protein expression levels. Flow cytometry, sphere formation assays, and Transwell experiments were employed to assess cancer cell stemness, migration, and invasion. Additionally, a kit was used to measure changes in glutamine metabolism‐related indicators.
Results
In this study, we found that knocking down HDAC4 expression inhibited the expression of SRY‐box transcription factor 2 (SOX2), octamer‐binding transcription factor 4 (OCT4), and nanog homeobox (NANOG) in A549 cells; it also reduced the proportions of CD133‐ and CD44‐positive cells and suppressed their sphere formation, cell migration, and invasion abilities. Furthermore, HDAC4 knockdown inhibited glutamine uptake, glutamate production, α‐ketoglutarate levels, and glutaminase (GLS) activity. Notably, treatment with the additional glutamine metabolism inhibitor CB‐839 attenuated the promoting effects of HDAC4 overexpression on the stemness, migration, and invasion of A549 cells. In addition, HDAC4 promoted the expression of hypoxia‐inducible factor‐1 alpha (HIF‐1α) and solute carrier family 38 member 2 (SLC38A2); after overexpressing HIF‐1α, the inhibitory effect of HDAC4 knockdown on SLC38A2 expression in A549 cells was weakened.
Conclusion
Our study reveals a critical mechanism by which HDAC4 enhances glutamine metabolism through upregulation of HIF‐1α expression to promote SLC38A2 expression, thereby driving NSCLC stemness and progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anorectal Diseases, The First People's Hospital of Yunnan Province, Kunming University of Science and Technology Affiliated Hospital, Kunming 650032, China, ypfph.com.
- Department of Anorectal Diseases, The First People's Hospital of Yunnan Province, School of Medicine, Kunming University of Science and Technology, Kunming 650032, China, kmust.edu.cn.
- School of Medicine, Yunnan University, Kunming 650500, China, ynu.edu.cn.
ORCID-Profile: Weimin Bao, Weijun Liu
Förderung
- Joint Special Fund of Kunming Medical University-Key Project
Zitieren
APA
Chen, C., Jiang, X., Yao, Z., Sun, J., Zhang, L., Xu, M., Bao, W., & Liu, W. (2026). HDAC4 Promotes Cancer Stemness in Nonsmall Cell Lung Cancer by Upregulating SLC38A2 Expression via HIF‐1α to Enhance Glutamine Metabolism. Analytical Cellular Pathology. https://doi.org/10.1155/ancp/2525721
Vancouver
Chen C, Jiang X, Yao Z, Sun J, Zhang L, Xu M, et al. HDAC4 Promotes Cancer Stemness in Nonsmall Cell Lung Cancer by Upregulating SLC38A2 Expression via HIF‐1α to Enhance Glutamine Metabolism. Analytical Cellular Pathology. 2026. doi:10.1155/ancp/2525721
BibTeX
@article{Chen2026,
author = {Chen, Changxian and Jiang, Xiaoming and Yao, Zhenwu and Sun, Jiaxue and Zhang, Liju and Xu, Mingyu and Bao, Weimin and Liu, Weijun},
title = {HDAC4 Promotes Cancer Stemness in Nonsmall Cell Lung Cancer by Upregulating SLC38A2 Expression via HIF‐1α to Enhance Glutamine Metabolism},
journal = {Analytical Cellular Pathology},
year = {2026},
doi = {10.1155/ancp/2525721}
}
EUVIMED